腾讯申请抗体序列生成方法相关专利，提升生成抗体序列的准确性

Group 1 - Tencent Technology (Shenzhen) Co., Ltd. has applied for a patent titled "Method, Device, Electronic Equipment, and Storage Medium for Generating Antibody Sequences" with publication number CN120412731A, filed on February 2024 [1] - The patent application describes a method for generating antibody sequences, which includes obtaining antigen sequence information and epitope information, encoding the antigen sequence information, and predicting the probability of amino acids at each position in the antibody sequence [1] - The company has a registered capital of 200 million USD and has invested in 15 enterprises, participated in 262 bidding projects, and holds 5000 trademark and patent information records [2]